Background Ultrasound pleural irregularity (PI-US) is a novel promising tool for non-invasive diagnosis of interstitial lung involvement (ILD) in connective tissue diseases (CTDs). Few data are available on its diagnostic usefulness in primary Sjögren's syndrome (pSS)-induced ILD.
Objectives a) To assess the accuracy of PI-US to diagnose ILD in pSS when compared to chest tomography (HRCT) (i.e gold standard imaging technique); b) to explore PI-US diagnostic value in early preclinical phases of lung involvement.
Methods PI-US was performed by a single operator using a MyLab-25 (Esaote), 10 MHz, 5 cm linear probe. PI was defined as the loss of the normal hyperechoic linear pleural contour (score 0–2: normal, minimal and major changes at each intercostal space). Abnormal findings at HRCT were quantified by an expert radiologist according to a semiquantitative score (0–2: absent, moderate, severe). Semi-quantitative scores assigned by PI-US and HRCT to 6 lung fields (2 for the anterior, 2 for postero-superior and 2 for postero-inferior chest surface) were compared. Total and partial scores (for each lung fields) were evaluated. For statistical analysis chi-square, Mann-Whitney test, R-Spearman, and ROC-curve analysis were used.
Results Validation study phase (PI-US vs HRCT): To validate PI-US technique, we enrolled 32 pSS patients [M/F:5/27; median age (IQR): 67 yrs (51.5–71); median disease duration (IQR): 7 (4–11) yrs; anti-Ro/SSA (+) 78.1%]. To be included patients should have performed a HRCT evaluation within 6 months. Thirteen patients (41%) presented HRCT lesions suggestive for ILD. HRCT total scores and PI-US total scores were strongly correlated (r=0.744, p=0.000). Similarly, PI-US and HRCT partial scores related to the postero-inferior fields showed a strong correlation one to each other (r=0.780, p=0.000). ROC-curve analysis identified a total PI-US score of 28.5 (Youden index) as able to predict HRCT-diagnosis of ILD with a sensitivity (SE) of 84.6% and a specificity (SP) of 89.5%. Analogously, a postero-inferior PI-US score of 12.5 demonstrated a SE of 100% and a SP of 89.5% for the ILD diagnosis. Prospective study phase exploring the usefulness of PI-US for ILD early pre-clinical diagnosis: We included 24 consecutive pSS patients without overt respiratory symptoms [M/F:1/23; median age (IQR): 55 yrs (47–67); median disease duration (IQR): 4 yrs (1–12); anti-Ro/SSA (+) 60.9%]. Out of them, at the end of the diagnostic work -up, four new cases of HRCT-proven pSS-ILD were diagnosed. Their PI-US mean total score was significantly higher than that observed in non-ILD patients (48±18 vs 16±12, p=0.001) as well as their mean postero-inferior PI-US score (19±9 vs 6±5, p=0.003). The total PI-US and postero-inferior PI-US cut-off retrieved in the first part of the study (i.e. 28.5 and 12.5) allowed us to identify those patients with an HRCT-proven pSS-ILD with a SE of 75% and 100%, a SP of 95% and 89.5%, a PPV of 75% and 57% and a NPV of of 95% and 100%, respectively.
Conclusions Even if preliminary, this study demonstrated a strong correlation between PI-US and HRCT in the detection of ILD-pSS also in asymptomatic patients, opening new perspectives for the early non-invasive screening of lung involvement in pSS.
Disclosure of Interest None declared
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.